This page in Swedish

Anders Vikerfors

Position: Doctoral Student School/office: School of Medical Sciences

Email: YW5kZXJzLnZpa2VyZm9ycztvcnUuc2U=

Phone: +46 019 6021694

Room: -

Research subject

Publications

Vikerfors, A. , Davidsson, S. , Carlsson, J. & Jerlström, T. (2024). Plasma Levels of Pentraxin 3: A Potential Prognostic Biomarker in Urinary Bladder Cancer Patients. International Journal of Molecular Sciences, 25 (6). [BibTeX]
Vikerfors, A. , Davidsson, S. , Janusz, F. , Jerlström, T. & Carlsson, J. (2021). Soluble PD-L1 in Serum and Urine in Urinary Bladder Cancer Patients. Cancers, 13 (22). [BibTeX]
Böös, M. , Jerlström, T. , Beckman, E. , Bläckberg, M. , Brändstedt, J. , Kollberg, P. , Löfgren, A. , Malmström, P. & et al. (2019). Who should record surgical complications?: Results from a third-party assessment of complications after radical cystectomy. Scandinavian journal of urology, 53 (5), 339-343. [BibTeX]

Carlsson, J. , Vikerfors, A. , Frey, J. , Jerlström, T. & Davidsson, S. (2019). Is soluble PD-L1 a potential biomarker for urothelial bladder cancer?. Paper presented at Keystone Symposia Conference 2019: Cancer metastasis: The role of metabolism, immunity and the microenvironment, Florens, Italy, March 15-19, 2019. [BibTeX]
Carlsson, J. , Vikerfors, A. , Frey, J. , Jerlström, T. & Davidsson, S. (2019). Är nivåer av cirkulerande CD163 associerat med kliniska parametrar för urinblåsecancer?. In: Svensk Urologi. Paper presented at Urologidagarna 2019, Västerås, Sweden, 2-4 October, 2019. (pp. 53-53). Svensk Urologisk Förening. [BibTeX]

Böös, M. , Jerlström, T. , Beckman, E. , Bläckberg, M. , Brändstedt, J. , Kollberg, P. , Löfgren, A. , Malmström, P. & et al. Who should record surgical complications? Results from a third-party assessment of complications after radical cystectomy. [BibTeX]